Patents by Inventor Brijesh Kumar Shukla

Brijesh Kumar Shukla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONTINUOUS PROCESS FOR THE PREPARATION OF 2-(1H-IMIDAZOL-4-YL) ETHANAMINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    Publication number: 20210361785
    Abstract: The present invention relates to stable pharmaceutical compositions of sulfur colloid, which advantageously provide a high radiochemical purity to 99mTc-pertechnetate without causing the gel formation. The compositions include pre-lyophilized and lyophilized compositions of sulfur colloid. It also relates to a non-radioactive kit which upon reconstitution with 99mTc-pertechnetate solution gives stabilized 99mmTc-Sulfur colloid radiopharmaceutical composition. Further, the process for preparation of said compositions and their use for diagnostic purposes are also disclosed.
    Type: Application
    Filed: October 7, 2019
    Publication date: November 25, 2021
    Applicant: Jubilant Generics Limited
    Inventors: Sanjeev Kumar, Rajesh Kumar, Brijesh Kumar Shukla, Rajendra Singh Shekhawat, Sujay Biswas, Dharam Vir, Nirmal Kumar, Indranil Nandi
  • Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof
    Patent number: 10889549
    Abstract: The invention relates to a commercially viable, cost effective and energy efficient process for the preparation of 2-(1H-Imidazol-4-yl)ethanamine or pharmaceutically acceptable salts thereof in high purity and yield via application of continuous flow technology.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: January 12, 2021
    Inventors: Sanjeev Kumar, Rajesh Kumar, Brijesh Kumar Shukla, Rajendra Singh Shekhawat, Sujay Biswas, Dharam Vir, Nirmal Kumar, Indranil Nandi
  • CONTINUOUS PROCESS FOR THE PREPARATION OF 2-(1H-IMIDAZOL-4-YL) ETHANAMINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    Publication number: 20200131137
    Abstract: The invention relates to a commercially viable, cost effective and energy efficient process for the preparation of 2-(1H-Imidazol-4-yl)ethanamine or pharmaceutically acceptable salts thereof in high purity and yield via application of continuous flow technology.
    Type: Application
    Filed: January 2, 2020
    Publication date: April 30, 2020
    Applicant: Jubilant Generics Limited
    Inventors: Sanjeev Kumar, Rajesh Kumar, Brijesh Kumar Shukla, Rajendra Singh Shekhawat, Sujay Biswas, Dharam Vir, Nirmal Kumar, Indranil Nandi